Research Expertise:

• Research and Publications: • Co-Investigator: I-2220321: Utilizing Patient Reported Quality of Life to Inform Patient Decision- Making in Early-Stage Lung Cancer. • Co-Investigator: IC-1171721: A Phase I/2 Study of M3814 (Peposertib) In Combination with Hypofractionated Radiotherapy for the Treatment of Locally Advanced Pancreatic Adenocarcinoma. • Co-Investigator: I-1307721: A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) In Central Non-Small Cell Lung Cancer. • Co-Investigator: I-50717: Three Pilot Studies of Stereotactic Body Radiation Therapy (SBRT) and Surgery in Non-Small Cell Lung Cancer. • Co-Investigator: I-81919: A Feasibility and Toxicity Analysis of Single Fraction Stereotactic Body Radiation Therapy for Post-Operative Non-Small Cell Lung Cancer. • Co-Investigator: I-81318: A Phase 2 Randomized Study with A Non-Randomized Cohort: Assessing Single-Fraction SBRT Versus Standard Palliative Radiation in Patients with Metastatic Disease (ASTEROID). • Co-Investigator: P-3772923: A Phase 1 study of JNJ-86974680, an A2a receptor antagonist, administered as monotherapy and in combination with cetrelimab and radiotherapy for advanced non-small cell lung cancer. • N. K. Malik, M. K. Farrugia, H. Yu, K. Wang, D. Neimanis, S. J. Ma, and A. K. Singh; A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer, Oral presentation ASTRO 2024 • Fatemeh Fekrmandi, John Michael Bryant, Beth Neilsen, Daniel Cherry, Revathi Myneni, Tugce Ozgen, Tyce Schneider, Nadia Malik, Russell Palm, Ann Raldow, Karyn Goodman, Amol Narang, Rachit Kumar, Maged Ghaly, Leonid Cherkassky, Benjamin Calvo, Todd Aguilera, Eric Miller, James Murphy, Smith Apisarnthanarax, Mary Feng, Hannah Roberts, Carrie: Neoadjuvant Radiation Practice Patterns in Resected Pancreatic Ductal Adenocarcinoma at Academic Cancer Centers Participating in the Canopy Cancer Collective Learning Health Network, Poster presentation ASTRO 2024 • Austin J Iovoli, Han Yu, Pragati G Advani , Lauren Turecki, Harish K Malhotra, Nadia Malik, Simon Fung-Kee-Fung, Anurag K Singh, Mark K Farrugia. Sinoatrial Node Dose Is Associated with Worse Survival in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Cancers. 2023 Oct 5:S1879-8500(23)00273-4. https://pubmed.ncbi.nlm.nih.gov/?term="Pract+Radiat+Oncol"[jour]&sort=date&sort_order=deschttps://www.ncbi.nlm.nih.gov/nlmcatalog?term="Pract+Radiat+Oncol"[Title+Abbreviation]https://pubmed.ncbi.nlm.nih.gov/37804882/doi: 10.1016/j.prro.2023.09.005. Online ahead of print. Affiliations expand PMID: 37804882. DOI: 10.1016/j.prro.2023.09.005. • Fatemeh Fekrmandi, Brendan Hagerty, Qian Liu, Tyce Schneider, N Malik, Christos Fountzilas, Moshim Kukar, Leonid Cherkassky, Benjamin Calvo* Neoadjuvant Chemotherapy Vs Upfront Resection, A Challenging Choice in Resectable Pancreatic Ductal Adenocarcinoma. GI ASCO 2024 • Huang K, Prasad S, Ma SJ, Iovoli AJ, Farrugia MK, Malik N, Singh AK. Comparison Of Survival Outcomes of Single-And Five-Fraction Schedules of Stereotactic Body Radiation Therapy for Early-Stage Central or Peripheral NSCLC Cancers. 2023; 15(6):1648. https://doi.org/10.3390/cancers15061648. • Malla M, Fekrmandi F, Nadia Malik, Hatoum H, George S, Goldberg RM, Mukherjee S. The Evolving Role of Radiation in Pancreatic Cancer. Front Oncol. 2023 Jan 11;12:1060885. doi: 10.3389/fonc.2022.1060885. PMID: 36713520; PMCID: PMC9875560. • Mark Farrugia, Han Yu, Sung Jun Ma, Austin J Iovoli, Saraswati Pokharel, Umesh C Sharma, Simon Fung-Kee-Fung, Nadia Malik, Anurag Singh, Harish Malhotra. Right Atrial Dose Is Associated with Worse Outcome in Patients Undergoing Definitive Stereotactic Body Radiation Therapy for Central Lung Tumors. Cancers (Basel). 2022 Mar 9;14(6):1391.doi: 10.3390/cancers14061391. • Austin J Iovoli, Sharan Prasad, Harish K Malhotra, Nadia Malik, Simon Fung-Kee-Fung, Anurag K Singh, Mark K Farrugia. Brachial Plexopathy After Single-Fraction Stereotactic Body Radiation Therapy in Apical Lung Tumors. Pract Radiat Oncol. 2022 Dec 26;S1879-8500(22)00387 3. doi:10.1016/j.prro.2022.12.002 • Midhun Malla, Fatemeh Fekrmandi, Nadia Malik, Hassan Hatoum, Sagila George, Richard M Goldberg, Sarbajit Mukherjee . The Evolving Role of Radiation in Pancreatic Cancer. Front Oncol. 2023 Jan 11;12:1060885. doi:10.3389 /fonc.2022.1060885. eCollection 2022. • Narang AK, Hill CS, Ghaly M, Korah B, Miller ED, Malik N, Raldow A, Anwar M, Sanford NN, Aguilera TA, Kim E, Apisarnthanarax S, Murphy JD, Frakes JM, Hoffe S, Schefter T, Chang DT, Hong TS, Herman JM, Goodman KA. Current Practice Patterns Among Radiation Oncologists at High Volume Pancreatic Cancer Centers Participating in the Canopy Cancer Collective Learning Health Network. ASTRO abstract submitted 2/2022. • J Kunnanchath, T Dufan, N Malik, A Salah, V Knight, K Singh, T Smith. Establishing Local Confidence Limit and Optimization of VMAT Patient Specific Quality Assurance. American Hospital, Dubai, ESTRO 2017: Physics-EP-1793. • G Yang, N Malik, R Chandrasekhar, W Ma, L Flaherty, R Iyer, B Kuvshinoff, J Gibbs, G Wilding, G Warren, K Salerno May. Change In CA 19-9 Levels After Chemoradiotherapy Predicts Survival in Patients with Locally Advanced Unresectable Pancreatic Cancer. Gastrointest Oncol 2013;4(4):361-369. • N. Malik, G. W. Warren, G. Yang, K. Zeeck, T. Papsidero, S. Patil, N. I. Khushalani, T. Sher, S. S. Yendamuri, H. R. Nava, K. Salerno May. Response Based Outcomes in Esophageal Cancer Patients Treated with Primarily Non-Cisplatin And 5-Fluorouracil Based Trimodality Therapy. J Clin Oncol 29: 2011 (suppl; abstr e14620). • K. Salerno May, N. Malik, G. Yang, S. Patil, L. Flaherty, N. I. Khushalani, T. Sher, S. S. Yendamuri, H. R. Nava, G. W. Warren. The Impact of Smoking History on Response and Survival Outcomes in Esophageal Cancer Patients Treated with Neoadjuvant Concurrent Chemoradiotherapy Followed by Surgery. J Clin Oncol 29: 2011 (suppl; abstr e14601). • N Malik, K Salerno May, R Chandrasekhar, N Watroba, L Flaherty, W Ma, B Kuvshinoff, G Wilding, J Gibbs, G Yang. Treatment Of Locally Advanced Unresectable Pancreatic Cancer: A 10-Year Experience. J Gastrointest Oncol. 2012 Dec;3(4):326-34.